• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Johnson & Johnson (NY:JNJ)

    185.63 -0.94 (-0.50%)
    Streaming Delayed Price Updated: 9:45 AM EST, Nov 10, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Johnson & Johnson

    All the Stocks Warren Buffett Bought in the Last 2 Recessions: Are They Smart Picks Now?
    Via The Motley Fool
    Topics Economy Government World Trade
    Amid Market Chaos, Don't Do This
    Markets are under some duress, but the action should not cause you to change your thesis. While markets are facing headwinds, it’s important to realize that stocks are under duress in what feels like a... 
    Via Talk Markets
    Topics Stocks / Equities
    President Trump's Tariffs Have Arrived. 3 Things to Do to Protect Your Portfolio.
    Via The Motley Fool
    Topics Economy Government Stocks
    Sit Out Market Drama With These 3 Dividend Funds
     
    Via Benzinga
    Johnson & Johnson's Tremfya Shows Efficacy In Late-Stage Psoriatic Arthritis Study
    Johnson & Johnson's Phase 3b APEX study shows Tremfya reduces symptoms and structural damage in psoriatic arthritis patients with no new safety concerns. 
    Via Benzinga
    Trump's Tariff Exemptions Include Semiconductors, Pharmaceuticals, Oil And More
    President Donald Trump on Wednesday announced a slew of tougher-than-anticipated tariffs, but there are some notable exemptions to the steep levies. Here's a look at which products and sectors are... 
    Via Benzinga
    Topics Government World Trade
    Man With $30K To Deploy Wants Dividends For Life – 'Even If It's Just Enough To Pay For A Yearly Vacation Here Or There,' Reddit Reacts
    For many investors, dividend-focused stocks and funds provide a way to generate passive income, whether to supplement retirement, cover day-to-day 
    Via Benzinga
    Topics Retirement
    Worried About the Economy? 2 No-Brainer Buys to Shield Your Portfolio.
    Via The Motley Fool
    Topics Earnings Economy Government
    What 13 Analyst Ratings Have To Say About Johnson & Johnson
     
    Via Benzinga
    Stock Of The Day: Will Johnson & Johnson Rally? The Sell-Off May Have Ended
    Shares of Johnson & Johnson (JNJ) sold off on news regarding a dilution of its earnings. The selloff ended when it reach support. 
    Via Benzinga
    Johnson & Johnson Closes Landmark Intra-Cellular Therapies, Inc. Acquisition to Solidify Neuroscience Leadership
    From Johnson & Johnson
    Via Business Wire
    J&J Retail Traders Unfazed By Court Rejecting 3rd Talc Settlement, But Analyst Sees Stock Pullback Risk
    According to Bloomberg, a monthly prescription of Zepbound via Hims' platform would cost $1,899 — $800 more than Lilly's list price for the drug. 
    Via Stocktwits
    Topics Bankruptcy Lawsuit
    Newsmax, Waton Financial, Johnson & Johnson, Hims & Hers Health, Tesla: Why These 5 Stocks Are On Investors' Radars Today
    U.S. stocks closed higher on Tuesday, with the Nasdaq Composite climbing 0.9% to 17,449.89. The S&P 500 added nearly 0.4%, finishing at 5,633.07. 
    Via Benzinga
    Topics Stocks
    Uncover the latest developments among S&P500 stocks in today's session.
    Curious about the S&P500 stocks that are in motion on Tuesday? Join us as we explore the top movers within the S&P500 index during today's session. 
    Via Chartmill
    Johnson & Johnson Announces Expected Closing Date for Intra-Cellular Acquisition
    From Johnson & Johnson
    Via Business Wire
    Johnson & Johnson Stock Is Tumbling Tuesday: What Going On?
    Johnson & Johnson Inc. (NYSE: JNJ) shares are trading lower Tuesday after a U.S. bankruptcy court in Texas rejected subsidiary Red River Talc's request to approve its prepackaged bankruptcy plan. 
    Via Benzinga
    Topics Bankruptcy
    Why Johnson & Johnson Stock Is Sinking Today
    Via The Motley Fool
    Topics Bankruptcy Lawsuit Stocks
    Exploring the top movers within the S&P500 index during today's session.
    Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Tuesday. 
    Via Chartmill
    Stocks Edge Higher Despite Trade, Economic Jitters
    Stocks are modestly higher Tuesday afternoon, as Wall Street shakes off a sluggish open amid a new wave of economic data. 
    Via Talk Markets
    Topics Stocks / Equities
    Wall Street Inches Up Ahead Of Tariff Day: What's Driving Markets Tuesday?
    Following the worst quarterly performance for U.S. stocks in over two years, caution dominated Wall Street as investors awaited details on the tariff plans expected from the Trump administration on... 
    Via Benzinga
    Topics Government World Trade
    These S&P500 stocks are gapping in today's session
    Seeking insights into today's market movers? Discover the S&P500 gap up and gap down stocks in today's session on Tuesday. Stay informed about the latest market trends. 
    Via Chartmill
    Why Johnson & Johnson (JNJ) Shares Are Falling Today
    Shares of multinational healthcare company Johnson & Johnson (NYSE:JNJ) fell 5.6% in the morning session after a judge in Texas rejected the company's third attempt to use bankruptcy as a legal shield... 
    Via StockStory
    Topics Bankruptcy Lawsuit
    US Manufacturing Slips Into Contraction As Tariff-Driven Costs Hit Near 3-Year High
    The brief revival in U.S. factory activity vanished in March as input prices shot up at the fastest pace since mid-2022, raising red flags about eroding profit margins, cost pass-through risks and... 
    Via Benzinga
    These S&P500 stocks are moving in today's pre-market session
    Pre-market stock analysis of S&P500 stocks on 2025-04-01: top gainers and losers in today's session. 
    Via Chartmill
    J&J Dives After Judge Tosses Out $10 Billion Talc-Based Bankruptcy Plan
    The company says it will return to the civil court system to handle tens of thousands of claims its talc-based products caused cancer. 
    Via Investor's Business Daily
    Topics Bankruptcy Lawsuit
    US Judge Rejects Another Johnson & Johnson Attempt To Use Bankruptcy For Talc Cancer Claims
    Johnson & Johnson will fight talc lawsuits in court after its subsidiary's bankruptcy plan was denied, reversing $7 billion in legal reserves. 
    Via Benzinga
    Topics Bankruptcy Lawsuit
    Federal Judge Rejects Johnson & Johnson Bankruptcy Strategy, Paving Way for Talc Victims to Seek Justice in Trial Courts
    From Beasley Allen Law Firm
    Via Business Wire
    2 Value Stocks I'm Buying Right Now
    Via The Motley Fool
    Topics Economy
    Johnson & Johnson to Return to Tort System to Defeat Meritless Talc Claims
    From Johnson & Johnson
    Via Business Wire
    Value Stocks Gain Ground As Inflation, Recession Fears Grow: 4 ETFs To Capitalize On The Trend
    Value stocks are outperforming flashy growth rivals due to market uncertainty, making value-based ETFs a good bet for steady income and diversification. 
    Via Benzinga
    Topics ETFs Economy
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.